EG vs RNR vs RGA
161 measures in 16 categories, one definition each, computed from filings and market data.
EG47.8
Everest Group, Ltd.
Financial Services · Insurance - Reinsurance
$389.10 +2.03%$14.9B mkt cap
Score DNA
RNR60.9
RenaissanceRe Holdings Ltd.
Financial Services · Insurance - Reinsurance
$351.06 +2.00%$14.6B mkt cap
Score DNA
RGA59.7
Reinsurance Group of America, Incorporated
Financial Services · Insurance - Reinsurance
$266.75 +1.00%$17.4B mkt cap
Score DNA
Price, rebased to 100 three years ago
EG RNR RGA · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | EG | RNR | RGA |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 1 | 0 | 0 |
| Last Congress purchase | 2026-03-27 | — | — |
| 13F net change in holders | — | +17 | +18 |
| ETFs adding shares, 30d | 308 | 320 | 361 |
| ETFs trimming, 30d | 333 | 299 | 290 |
| Net ETF funds, 30d | −25 | +21 | +71 |
Valuation
16 measures| Measure | EG | RNR | RGA |
|---|---|---|---|
| P/E (TTM) | 7.8x
50th
|
5.5x
0th
|
11.6x
100th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 0.46
100th
|
0.06
25th
|
0.30
50th
|
| Price / sales | 0.9x
50th
|
1.4x
100th
|
0.7x
17th
|
| Price / book | 1.0x
17th
|
1.2x
33rd
|
1.3x
83rd
|
| Price / tangible book | 1.0x
33rd
|
1.2x
67th
|
1.0x
50th
|
| Price / free cash flow | n/a | n/a | n/a |
| Price / operating cash flow | n/a | n/a | n/a |
| Enterprise value | n/a | n/a | n/a |
| EV / sales | n/a | n/a | n/a |
| EV / EBITDA | n/a | n/a | n/a |
| EV / EBIT | n/a | n/a | n/a |
| EV / free cash flow | n/a | n/a | n/a |
| Earnings yield | 12.8%
50th
|
18.1%
100th
|
8.7%
0th
|
| FCF yield | n/a | n/a | n/a |
| Operating cash flow yield | n/a | n/a | n/a |
| Graham number (per share) | $639.74
100th
|
$637.01
83rd
|
$323.02
50th
|
Profitability (TTM)
12 measures| Measure | EG | RNR | RGA |
|---|---|---|---|
| Gross margin | n/a | n/a | n/a |
| EBITDA margin | n/a | n/a | n/a |
| Operating margin | 15.4%
50th
|
38.8%
100th
|
7.3%
0th
|
| EBIT margin | 15.8%
50th
|
39.9%
100th
|
8.9%
17th
|
| Net margin | 11.5%
50th
|
24.7%
100th
|
5.9%
0th
|
| NOPAT margin | 12.9%
50th
|
34.9%
100th
|
5.9%
0th
|
| FCF margin | n/a | n/a | n/a |
| Operating cash flow margin | n/a | n/a | n/a |
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 11.6%
83rd
|
8.0%
67th
|
0.0%
0th
|
| Stock comp / revenue | 0.3%
50th
|
0.0%
0th
|
0.0%
0th
|
| Effective tax rate | 16.3%
67th
|
9.9%
33rd
|
19.2%
83rd
|
Returns on capital
11 measures| Measure | EG | RNR | RGA |
|---|---|---|---|
| ROE (on average equity) | 12.6%
50th
|
23.3%
100th
|
11.7%
17th
|
| ROA | 3.1%
50th
|
4.8%
83rd
|
1.0%
0th
|
| ROIC | n/a | n/a | n/a |
| ROCE | n/a | n/a | n/a |
| Return on tangible assets | 4.3%
50th
|
7.7%
83rd
|
1.5%
0th
|
| Cash ROIC (OCF / invested capital) | n/a | n/a | n/a |
| Gross profitability (GP / assets) | n/a | n/a | n/a |
| ROIC, 3-yr average | n/a | n/a | n/a |
| ROIC, 5-yr average | n/a | n/a | n/a |
| ROE, 5-yr average | 11.7%
100th
|
11.3%
75th
|
8.2%
50th
|
| Incremental ROIC | n/a | n/a | n/a |
Growth
17 measures| Measure | EG | RNR | RGA |
|---|---|---|---|
| Revenue growth (TTM YoY) | -4.6%
17th
|
-17.3%
0th
|
18.6%
50th
|
| Revenue growth (QoQ) | -2.6%
17th
|
9.1%
83rd
|
2.5%
33rd
|
| Revenue CAGR, 3 yr | 8.1%
40th
|
13.2%
60th
|
15.5%
80th
|
| Revenue CAGR, 5 yr | 8.3%
25th
|
16.1%
100th
|
10.3%
50th
|
| Gross profit CAGR, 3 yr | n/a | n/a | n/a |
| Operating income CAGR, 3 yr | 24.7%
25th
|
75.6%
100th
|
32.3%
75th
|
| Net income growth (TTM YoY) | 137.3%
83rd
|
31.8%
0th
|
95.8%
50th
|
| Net income CAGR, 3 yr | 16.4%
20th
|
85.4%
100th
|
37.1%
60th
|
| EPS growth (TTM YoY) | 148.8%
83rd
|
52.0%
17th
|
95.8%
50th
|
| EPS CAGR, 3 yr | 16.8%
20th
|
91.8%
80th
|
38.0%
60th
|
| EPS CAGR, 5 yr | 7.2%
25th
|
47.9%
100th
|
13.5%
75th
|
| FCF growth (TTM YoY) | n/a | n/a | n/a |
| FCF CAGR, 3 yr | n/a | n/a | n/a |
| Operating cash flow CAGR, 3 yr | n/a | n/a | n/a |
| Book value CAGR, 3 yr | 12.7%
20th
|
20.9%
60th
|
21.4%
80th
|
| Dividend CAGR, 3 yr | -1.3%
25th
|
1.0%
50th
|
1.9%
75th
|
| Sustainable growth rate | 10.4%
50th
|
22.3%
83rd
|
9.8%
17th
|
Margin history & stability
7 measures| Measure | EG | RNR | RGA |
|---|---|---|---|
| Gross margin, 3-yr average | n/a | n/a | n/a |
| Operating margin, 3-yr average | 12.5%
67th
|
30.7%
100th
|
5.9%
0th
|
| Net margin, 3-yr average | 11.6%
67th
|
21.9%
100th
|
4.5%
0th
|
| FCF margin, 3-yr average | n/a | n/a | n/a |
| Revenue stability (0-1) | 0.89
83rd
|
0.78
17th
|
0.89
67th
|
| Earnings stability (0-1) | 0.10
17th
|
0.66
83rd
|
0.46
50th
|
| Margin stability (0-1) | 0.67
67th
|
0.43
17th
|
0.59
33rd
|
Liquidity (latest quarter)
7 measures| Measure | EG | RNR | RGA |
|---|---|---|---|
| Cash & short-term investments | n/a | n/a | n/a |
| Net cash (− = net debt) | n/a | n/a | n/a |
| Working capital | n/a | n/a | n/a |
| Current ratio | n/a | n/a | n/a |
| Quick ratio | n/a | n/a | n/a |
| Cash ratio (cash + ST investments / current liabilities) | n/a | n/a | n/a |
| Defensive interval (days) | n/a | n/a | n/a |
Leverage & solvency (latest quarter)
13 measures| Measure | EG | RNR | RGA |
|---|---|---|---|
| Total debt | n/a | n/a | n/a |
| Debt / equity | n/a | n/a | n/a |
| Net debt / equity | n/a | n/a | n/a |
| Debt / assets | n/a | n/a | n/a |
| Debt / capital | n/a | n/a | n/a |
| Debt / EBITDA | n/a | n/a | n/a |
| Net debt / EBITDA | n/a | n/a | n/a |
| Interest coverage (EBIT / interest) | n/a | n/a | n/a |
| Cash interest coverage | n/a | n/a | n/a |
| Debt payback (years of OCF) | n/a | n/a | n/a |
| Liabilities / assets | 75.2%
50th
|
65.3%
0th
|
91.8%
83rd
|
| IS credit model rating | AA | AA+ | BBB+ |
| Implied credit spread (bps) | 80
50th
|
65
0th
|
225
100th
|
Efficiency
11 measures| Measure | EG | RNR | RGA |
|---|---|---|---|
| Asset turnover | n/a | n/a | n/a |
| Fixed asset turnover | n/a | n/a | n/a |
| Inventory turnover | n/a | n/a | n/a |
| Receivables turnover | n/a | n/a | n/a |
| Days sales outstanding | n/a | n/a | n/a |
| Days inventory outstanding | n/a | n/a | n/a |
| Days payables outstanding | n/a | n/a | n/a |
| Cash conversion cycle (days) | n/a | n/a | n/a |
| Capex / revenue | n/a | n/a | n/a |
| Capex / depreciation | n/a | n/a | n/a |
| Operating expense ratio | n/a | n/a | n/a |
Cash flow & earnings quality
7 measures| Measure | EG | RNR | RGA |
|---|---|---|---|
| Operating cash flow / net income | n/a | n/a | n/a |
| FCF / net income | n/a | n/a | n/a |
| FCF / operating cash flow | n/a | n/a | n/a |
| Capex / operating cash flow | n/a | n/a | n/a |
| Accruals ratio | n/a | n/a | n/a |
| Sloan accruals ratio | n/a | n/a | n/a |
| Earnings quality score (0-1) | n/a | n/a | n/a |
Scores & forensic checks
15 measures| Measure | EG | RNR | RGA |
|---|---|---|---|
| IS score | 48
0th
|
61
83rd
|
60
50th
|
| IS profitability | 46
50th
|
82
100th
|
31
17th
|
| IS growth | 53
17th
|
44
0th
|
71
50th
|
| IS value | 87
33rd
|
88
83rd
|
86
17th
|
| IS momentum | 77
33rd
|
75
17th
|
96
67th
|
| IS risk (safety) | 100
33rd
|
100
33rd
|
65
17th
|
| IS quality | 74
67th
|
86
83rd
|
74
33rd
|
| IS balance sheet | 64
33rd
|
72
50th
|
55
0th
|
| IS earnings quality | 70
33rd
|
71
67th
|
77
83rd
|
| IS cash flow | 50
0th
|
87
67th
|
78
33rd
|
| Piotroski F-score (0-9) | 7
50th
|
6
0th
|
8
67th
|
| Altman Z-score | — | — | — |
| Beneish M-score | — | — | — |
| Ohlson O-score | −6.49
67th
|
−7.99
0th
|
−6.65
33rd
|
| IS credit score | 87
50th
|
93
67th
|
65
0th
|
Size (TTM)
8 measures| Measure | EG | RNR | RGA |
|---|---|---|---|
| Market cap | $14.9B
67th
|
$14.6B
50th
|
$17.4B
100th
|
| Revenue | $16.7B
67th
|
$10.7B
50th
|
$25.7B
83rd
|
| EBITDA | $2.6B
83rd
|
$4.2B
100th
|
$2.3B
50th
|
| Net income | $1.9B
83rd
|
$2.6B
100th
|
$1.5B
50th
|
| Free cash flow | n/a | n/a | n/a |
| Total assets | $62.2B
67th
|
$55.2B
50th
|
$167.1B
83rd
|
| Shareholders' equity | $15.4B
100th
|
$11.8B
50th
|
$13.7B
67th
|
| Employees | 3,064
67th
|
1,040
33rd
|
4,300
100th
|
Price performance
9 measures| Measure | EG | RNR | RGA |
|---|---|---|---|
| 1 day | +2.0% | +2.0% | +1.0% |
| 1 week | +5.6% | +5.9% | +4.2% |
| 1 month | +2.4% | +6.8% | +8.5% |
| 3 months | +2.7% | +9.2% | +10.7% |
| 6 months | +10.7% | +11.4% | +26.3% |
| Year to date | +16.3% | +28.9% | +31.6% |
| 1 year | +12.3% | +35.2% | +39.3% |
| 3 years, cumulative | +4.0% | +67.1% | +90.5% |
| 5 years, cumulative | +58.6% | +146.2% | +143.7% |
Technicals
4 measures| Measure | EG | RNR | RGA |
|---|---|---|---|
| RSI 14 | 66.9 | 73.2 | 73.4 |
| From 52-week high | −3.0% | −0.0% | −0.2% |
| From 52-week low | +29.5% | +52.1% | +50.4% |
| Beta | 0.26 | 0.17 | 0.45 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17